Skip to main content
Equibles
CRVS logo

CRVS · Corvus Pharmaceuticals, Inc. · Short Interest

Track CRVS — free

Use CRVS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CRVS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$10.68 +0.03 (+0.28%)
Russell 2000 member Rebalance outlook locked
Market Cap
$885.79M
Shares
84.12M
Volume · Oct 23 933.82K Avg daily vol (3M) 991.43K

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

Pull short interest history through the short interest API or MCP →

CRVS Latest Reported Short Interest

FINRA reported 17,797,751 CRVS shares sold short as of the September 30, 2026 settlement date, an increase of 617,410 shares. Days to cover was 13.31 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent splits of this listing

CRVS Short Interest Forecast

Equibles' model estimates 17,934,946 shares sold short for the October 15, 2026 settlement, +0.8% versus the latest reported position, with a likely range of 16,483,360 to 19,502,906 shares. This model prediction uses FINRA data through October 15, 2026; FINRA's official release is expected October 26, 2026.

Model estimate

Expected Oct 15 short interest

as of Oct 15 Low confidence 56% chance it falls
17,934,946 +0.8% vs reported
Likely range 16,483,360 to 19,502,906 The latest estimate appears in the chart below. Official release expected Oct 26. Methodology
Short Squeeze Score
80/100
Short interest 21.2% of shares — P98 Days to cover 13.3 — P95 Price vs VWAP -15.4% — P29 Short-volume trend +18.9% — P94 Short interest change +3.6% — P60 Worst FTD 0.05% of shares — P75

Positioning score 80.4 + catalyst boost 0 (total capped at 100). This is a screening index, not a probability of a squeeze.

Method and coverage limits

Factor percentiles compare eligible primary operating-company stocks reporting short interest at the latest settlement date (2026-09-30). The weighted mean uses short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, and fails-to-deliver 10%. Missing factors redistribute their weight; incomplete coverage is not evidence of low risk. Price, volume, and earnings boosts add 10 each, capped at 20.

Shares outstanding are not free float. Borrow fees, utilization, lendable supply, recalls, and dealer inventory are not measured. Short-sale volume does not measure the change in open shorts; fails to deliver are not a borrow-cost measurement; price vs VWAP does not establish short sellers' entry prices. Earnings can move prices in either direction.

The weights are judgment-based, not calibrated to future squeeze outcomes. The separate options assessment below does not change this universe ranking.

Options positioning & squeeze sensitivity

Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.

Open interest is incomplete, stale, or dated inconsistently; positioning totals are unavailable.

Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.

Assessment prepared 2026-10-23 23:40 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.

1M 3M 6M 1Y 5Y All
Dimensions
  • Add to chart

    • Short Interest History

    Settlement Date Current Position Previous Position Change Days to Cover
    2026-10-30 Scheduled
    FINRA publishes Nov 10
    		 — — — —
    2026-10-15 Scheduled
    FINRA publishes Oct 26
    		 — — — —
    2026-09-30 17,797,751 17,180,341 +617,410 13.31
    2026-09-15 17,180,341 19,017,840 -1,837,499 18.16
    2026-08-31 19,017,840 19,127,098 -109,258 29.64
    2026-08-14 19,127,098 18,310,256 +816,842 22.53
    2026-07-31 18,310,256 18,061,919 +248,337 22.50
    2026-07-15 18,061,919 18,819,891 -757,972 12.59
    2026-06-30 18,819,891 17,882,834 +937,057 12.38
    2026-06-15 17,882,834 17,324,311 +558,523 14.37
    2026-05-29 17,324,311 18,910,283 -1,585,972 8.45
    2026-05-15 18,910,283 18,385,941 +524,342 11.98
    2026-04-30 18,385,941 16,928,111 +1,457,830 11.54
    2026-04-15 16,928,111 16,951,894 -23,783 21.77
    2026-03-31 16,951,894 16,054,916 +896,978 11.09
    2026-03-13 16,054,916 16,009,857 +45,059 14.71
    2026-02-27 16,009,857 14,883,150 +1,126,707 13.29
    2026-02-13 14,883,150 14,678,521 +204,629 9.81
    2026-01-30 14,678,521 11,486,255 +3,192,266 1.09
    2026-01-15 11,486,255 11,816,663 -330,408 7.54
    2025-12-31 11,816,663 9,383,518 +2,433,145 6.47
    2025-12-15 9,383,518 9,812,924 -429,406 6.71
    2025-11-28 9,812,924 9,902,822 -89,898 12.97
    2025-11-14 9,902,822 9,028,415 +874,407 8.72
    2025-10-31 9,028,415 8,833,502 +194,913 8.88

    Full FINRA short interest reporting calendar

    Showing 1–23 of 23 settlements
    Key facts CIK 1626971 CUSIP 221015100 13F (30d) 15 filings 15 filers Visit website Investor relations